Zilis UltraCell Topical CBD Oil - Soothing Gel
Smooth & Silky Feel for Relief
Zilis UltraCell is a potent, full-spectrum water-soluble topical CBD gel. Crafted from USA hemp, UltraCell is rich in phytocannabinoids, and is expressed from the whole hemp plant. UltraCell topical gel contains Zilis' CBD oil, procured from a patented water-based technologyÂ
- Full-Spectrum, CBD Oil in a skin Gel
-

100% Water-Soluble for Best absorption
Â
-
Powerful Phytocannabinoids
, CO2 process
- Does not stain clothes
- USA Sourced CBD Oil
- Power-packed with vitamins, minerals, terpenes, flavonoids, & fatty acids
Ingredients:
CBD Blend-Full Spectrum Hemp Extract, Black Pepper Oil, Citronella Oil, Helichrysum Flower Oil, Ginger Root Oil, Organic Aloe Leaf, Meadowfoam Seed Oil, Menthol, Capsicum Fruit Oleoresin, White Camphor Bark Oil, Sweet Basil Leaf Oil, Roman Chamomile Flower Oil, German Chamomile Flower Oil, Cinnamon Leaf Oil, Eucalyptus Leaf Oil, Grapefruit Peel Oil, Juniper Berry Oil,Lemongrass Oil, Peppermint Oil, Pine Needle Oil, Ravensara Oil, Rosemary Leaf Oil, Spearmint Oil, Wild Oregano Oil, Organic Alcohol, Phenoxyethanol, Carbomer, Triethanolamine, Tetrasodium Glutamate Diacetate, Witch Hazel.
Directions: 
Rub a pea-sized amount to affected area as needed. Consult your healthcare provider before using. For external use only. Discontinue when discomfort or irritation occur. Do not ingest and keep away from eyes. Consult your healthcare provider before using. External Topical Use Only. Not intended for use by pregnant or nursing women or anyone under age 18. Keep out of reach of children.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
Â
The Department of Health and Human Services of the US Federal Government owns the patent #6,630,507.